Ve. Gould et al., IMMUNOLOCALIZATION OF GLYCOPROTEIN A-80 IN PROSTATIC-CARCINOMA AND PROSTATIC INTRAEPITHELIAL NEOPLASIA, Human pathology, 27(6), 1996, pp. 547-552
A-80 is a mucin-like glycoprotein associated with exocrine differentia
tion that shows little or no expression in normal exocrine cells and t
ypical adenomas, but is upregulated in dysplasia and adenocarcinoma of
certain organs. Its expression has not been systematically examined i
n prostatic adenocarcinoma and its putative precursor, prostatic intra
epithelial neoplasia (PIN). The authors applied a mouse monoclonal ant
ibody against A-80 in paraffin-embedded sections from 103 cases of pro
static carcinoma, 26 cases of nodular hyperplasia, 7 autopsy samples f
rom normal young adult prostates, and 12 fetal prostates. All but one
cancer reacted, although expression was heterogeneous; 75 of 103 stain
ed extensively (>3+ on a 0 to 5+ scale) and strongly. Staining extent
and intensity were independent of tumor grade, and tended to be strong
even when focal. Seventy-seven of 84 fod (92%) of high-grade PIN and
38 of 52 loci (73%) of low-grade PIN stained for A-80; reactions were
most extensive and intense in high grade PIN. Only 5 of 26 cases (19%)
of hyperplasia reacted, and this consisted of weak to moderate staini
ng in sporadic cells; the remainder were negative. Normal adult prosta
tic epithelium did not express A-80 except for weak and inconsistent s
taining in foci of inflammation and infarction; atrophic glands were n
egative. Fetal prostate showed focally strong reactivity. These result
s indicate that A-80 is selectively expressed in most cases of intraep
ithelial neoplasia and prostate cancer, but is usually absent in benig
n and hyperplastic epithelium. The upregulation of glycoprotein A-80 i
n PIN and adenocarcinoma parallels observations in other organs, such
as the breast and colon, suggesting that this is a significant oncodev
elopmental molecule with potential clinical applications. Copyright (C
) 1996 by W.B. Saunders Company